NIFTY 50

Rewind FY21: How Pharma sector performed in pandemic-hit year

Updated : March 31, 2021 04:34 PM IST

The onset of the COVID-19 pandemic brought into focus India's strong drug and vaccine manufacturing capabilities.

It soon became clear that Indian manufacturers, led by Serum Institute (which makes half of all vaccines in the world), will play a major role in combating the pandemic, not just in India but also globally.

The origin of the pandemic in China also shaped India's pharma sector. With global manufacturers moving facilities from China using the plus one strategy, API (active pharmaceutical ingredient) businesses of companies like Divi's Lab, Glenmark benefitted.

Watch the accompanying video of CNBC-TV18’s Ekta Batra for interesting details.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you